{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:49:10Z","timestamp":1787028550631,"version":"build-2736575974"},"reference-count":15,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["1 R61 HL154137-01A1"],"award-info":[{"award-number":["1 R61 HL154137-01A1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Barth Syndrome (BTHS) is an early onset, lethal X-linked disorder caused by a mutation in tafazzin (TAFAZZIN), a mitochondrial acyltransferase that remodels monolysocardiolipin (MLCL) to mature cardiolipin (CL) and is essential for normal mitochondrial, cardiac, and skeletal muscle function. Current gene therapies in preclinical development require high levels of transduction. We tested whether TAFAZZIN gene therapy could be enhanced with the addition of a cell-penetrating peptide, penetratin (Antp). We found that TAFAZZIN-Antp was more effective than TAFAZZIN at preventing the development of pathological cardiac hypertrophy and heart failure. These findings indicate that a cell-penetrating peptide enhances gene therapy for BTHS.<\/jats:p>","DOI":"10.3390\/ijms252413560","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T08:56:32Z","timestamp":1734512192000},"page":"13560","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-7992","authenticated-orcid":false,"given":"Rahul","family":"Raghav","sequence":"first","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Awata","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2959-4327","authenticated-orcid":false,"given":"Douglas","family":"Strathdee","sequence":"additional","affiliation":[{"name":"Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Blanton","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3065-8498","authenticated-orcid":false,"given":"Michael T.","family":"Chin","sequence":"additional","affiliation":[{"name":"Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Chin, M.T., and Conway, S.J. (2020). Role of Tafazzin in Mitochondrial Function, Development and Disease. J. Dev. Biol., 8.","DOI":"10.3390\/jdb8020010"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jimd.12453","article-title":"Current and future treatment approaches for Barth syndrome","volume":"45","author":"Thompson","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/hum.2018.020","article-title":"AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome","volume":"30","author":"Saha","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Suzuki-Hatano, S., Sriramvenugopal, M., Ramanathan, M., Soustek, M., Byrne, B.J., Cade, W.T., Kang, P.B., and Pacak, C.A. (2019). Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-TAZ Gene Delivery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143416"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome","volume":"126","author":"Wang","year":"2020","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dinca, A., Chien, W.M., and Chin, M.T. (2016). Intracellular Delivery of Proteins with Cell-Penetrating Peptides for Therapeutic Uses in Human Disease. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17020263"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2119\/molmed.2009.00163","article-title":"Alpha-galactosidase A-Tat fusion enhances storage reduction in hearts and kidneys of Fabry mice","volume":"16","author":"Higuchi","year":"2010","journal-title":"Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.biomaterials.2009.11.019","article-title":"Gene delivery using a derivative of the protein transduction domain peptide, K-Antp","volume":"31","author":"Min","year":"2010","journal-title":"Biomaterials"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1074\/jbc.M113.525733","article-title":"Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast","volume":"289","author":"Baile","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Perera, G., Power, L., Larson, A., Codden, C.J., Awata, J., Batorsky, R., Strathdee, D., and Chin, M.T. (2023). Single Cell Transcriptomic Analysis in a Mouse Model of Barth Syndrome Reveals Cell-Specific Alterations in Gene Expression and Intercellular Communication. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202306.1603.v1"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chou, C., Martin, G.L., Perera, G., Awata, J., Larson, A., Blanton, R., and Chin, M.T. (2023). A novel alphaB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1223244"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Durkin, M.E., Qian, X., Popescu, N.C., and Lowy, D.R. (2013). Isolation of Mouse Embryo Fibroblasts. Bio Protoc., 3.","DOI":"10.21769\/BioProtoc.908"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ab.2009.01.032","article-title":"Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome","volume":"387","author":"Houtkooper","year":"2009","journal-title":"Anal. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1373\/clinchem.2007.095711","article-title":"Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome","volume":"54","author":"Kulik","year":"2008","journal-title":"Clin. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13560\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:41Z","timestamp":1760115281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/24\/13560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":15,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["ijms252413560"],"URL":"https:\/\/doi.org\/10.3390\/ijms252413560","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}